Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Financings

Reviva Pharmaceuticals Holdings, Inc.

Financings

RaiseDate
Public offering of shares of common stock (or common stock equivalents) with Series E and Series F warrants
Update: about US$9M · US$0.335 a share · Warrants at US$0.335 · A.G.P./Alliance Global Partners
Dealers: A.G.P./Alliance Global Partners (lead)
Use of proceeds: Research and development activities, working capital and other general corporate purposes
Sep 19, 2025
Public offering of public equity offering
Closed: US$10M raised · US$0.5 a share · Warrants at US$0.5 · A.G.P./Alliance Global Partners
Dealers: A.G.P./Alliance Global Partners (lead)
Use of proceeds: Research and development activities, working capital and other general corporate purposes
Aug 14, 2025
Public offering of shares of common stock (or common share equivalents) and warrants
Announced: about US$18M · US$1.5 a share · Warrants at US$1.5 · Citizens JMP +1
Dealers: Citizens JMP (lead), Citizens JMP Securities, LLC (lead)
Use of proceeds: Fund research and development activities and for working capital and other general corporate purposes
Dec 16, 2024

Read by 6ix AI from the company's releases